StockGlow

Ampio Pharmaceuticals, Inc. (AMPE)

Develops pain-relief drugs for knee osteoarthritis

$0.18+0.00%Healthcare
Compare AMPE with
StockGlow Score
68
Leaning Bullish
BearishBullish
1 year ago+6213.8%

The outlook

AMPE is trading near the lower end of its 52-week range, positioned above both its 50- and 200-day moving averages. Analyst coverage appears thin. The current market lean is bullish overall, though the stock remains well below its recent highs.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range28% of the way from its 52-week low to high
Market cap
$207,884
52-wk high
$0.64
52-wk low
$0.00
50-day avg
$0.18
200-day avg
$0.13
Trailing P/E
—

Similar stocks

ATNMActinium Pharmaceuticals, Inc.$0.87+1.42%OGENOragenics, Inc.$0.50-0.80%TLPHTalphera, Inc.$1.30+3.17%CANFCan-Fite BioPharma Ltd.$3.16+0.32%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy